First look: how bodies process new drug differs by ethnicity
NCT ID NCT04497883
Summary
This early-stage study aimed to understand how a drug called maribavir is processed by the body in healthy Japanese adults compared to healthy Caucasian adults. It involved 24 healthy volunteers and tested single oral doses. The main goal was to see if the drug's levels in the blood were similar between the two groups and if increasing the dose in Japanese participants led to a predictable increase in those levels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
PPD Development, LP
Las Vegas, Nevada, 89113, United States
Conditions
Explore the condition pages connected to this study.